Curtailed T-cell activation curbs effector differentiation and generates CD8+ T cells with a naturally-occurring memory stem cell phenotype

Eur J Immunol. 2017 Sep;47(9):1468-1476. doi: 10.1002/eji.201646732. Epub 2017 Jul 28.

Abstract

Human T memory stem (TSCM ) cells with superior persistence capacity and effector functions are emerging as important players in the maintenance of long-lived T-cell memory and are thus considered an attractive population to be used in adoptive transfer-based immunotherapy of cancer. However, the molecular signals regulating their generation remain poorly defined. Here we show that curtailed T-cell receptor stimulation curbs human effector CD8+ T-cell differentiation and allows the generation of CD45RO- CD45RA+ CCR7+ CD27+ CD95+ -phenotype cells from highly purified naïve T-cell precursors, resembling naturally-occurring human TSCM . These cells proliferate extensively in vitro and in vivo, express low amounts of effector-associated genes and transcription factors and undergo considerable self-renewal in response to IL-15 while retaining effector differentiation potential. Such a phenotype is associated with a lower number of mitochondria compared to highly-activated effector T cells committed to terminal differentiation. These results shed light on the molecular signals that are required to generate long-lived memory T cells with potential application in adoptive cell transfer immunotherapy.

Keywords: Adoptive cell transfer; CD8+; Effector T cells; T memory stem cells; T-cell activation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult Stem Cells / physiology*
  • Animals
  • Antigens, CD / metabolism
  • CD8-Positive T-Lymphocytes / physiology*
  • Cancer Vaccines / immunology*
  • Cell Differentiation
  • Cell Proliferation
  • Cell Self Renewal
  • Cells, Cultured
  • Humans
  • Immunologic Memory
  • Immunophenotyping
  • Immunotherapy, Adoptive / methods*
  • Interleukin-15 / metabolism
  • Lymphocyte Activation
  • Mice
  • Mice, SCID
  • Neoplasms / immunology
  • Neoplasms / therapy*
  • Phenotype
  • Receptors, Antigen, T-Cell / metabolism

Substances

  • Antigens, CD
  • Cancer Vaccines
  • Interleukin-15
  • Receptors, Antigen, T-Cell